Atypical Hemolytic Uremic Syndrome (aHUS)

Also known as: Atypical Hemolytic Uremic Syndrome

DrugDrug NameDrug Description
DB01257EculizumabA recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
DrugDrug NameTargetType
DB01257EculizumabComplement C5target
DrugDrug NamePhaseStatusCount
DB15011Avacopan2Terminated1
DB01257Eculizumab2Completed7
DB01257Eculizumab2Recruiting1
DB14991Nomacopan3Recruiting1
DB11580Ravulizumab3Active Not Recruiting2
DB01257Eculizumab4Completed1